Cargando…
Effect of palmitoylation on the dimer formation of the human dopamine transporter
The human dopamine transporter (hDAT) is one in three members of the monoamine transporter family (MAT). hDAT is essential for regulating the dopamine concentration in the synaptic cleft through dopamine reuptake into the presynaptic neuron; thereby controlling hDAT dopamine signaling. Dysfunction o...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7893171/ https://www.ncbi.nlm.nih.gov/pubmed/33602981 http://dx.doi.org/10.1038/s41598-021-83374-y |
_version_ | 1783653012547305472 |
---|---|
author | Zeppelin, Talia Pedersen, Kasper B. Berglund, Nils A. Periole, Xavier Schiøtt, Birgit |
author_facet | Zeppelin, Talia Pedersen, Kasper B. Berglund, Nils A. Periole, Xavier Schiøtt, Birgit |
author_sort | Zeppelin, Talia |
collection | PubMed |
description | The human dopamine transporter (hDAT) is one in three members of the monoamine transporter family (MAT). hDAT is essential for regulating the dopamine concentration in the synaptic cleft through dopamine reuptake into the presynaptic neuron; thereby controlling hDAT dopamine signaling. Dysfunction of the transporter is linked to several psychiatric disorders. hDAT and the other MATs have been shown to form oligomers in the plasma membrane, but only limited data exists on which dimeric and higher order oligomeric states are accessible and energetically favorable. In this work, we present several probable dimer conformations using computational coarse-grained self-assembly simulations and assess the relative stability of the different dimer conformations using umbrella sampling replica exchange molecular dynamics. Overall, the dimer conformations primarily involve TM9 and/or TM11 and/or TM12 at the interface. Furthermore, we show that a palmitoyl group (palm) attached to hDAT on TM12 modifies the free energy of separation for interfaces involving TM12, suggesting that S-palmitoylation may change the relative abundance of dimers involving TM12 in a biological context. Finally, a comparison of the identified interfaces of hDAT and palmitoylated hDAT to the human serotonin transporter interfaces and the leucine transporter interface, suggests similar dimer conformations across these protein family. |
format | Online Article Text |
id | pubmed-7893171 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-78931712021-02-23 Effect of palmitoylation on the dimer formation of the human dopamine transporter Zeppelin, Talia Pedersen, Kasper B. Berglund, Nils A. Periole, Xavier Schiøtt, Birgit Sci Rep Article The human dopamine transporter (hDAT) is one in three members of the monoamine transporter family (MAT). hDAT is essential for regulating the dopamine concentration in the synaptic cleft through dopamine reuptake into the presynaptic neuron; thereby controlling hDAT dopamine signaling. Dysfunction of the transporter is linked to several psychiatric disorders. hDAT and the other MATs have been shown to form oligomers in the plasma membrane, but only limited data exists on which dimeric and higher order oligomeric states are accessible and energetically favorable. In this work, we present several probable dimer conformations using computational coarse-grained self-assembly simulations and assess the relative stability of the different dimer conformations using umbrella sampling replica exchange molecular dynamics. Overall, the dimer conformations primarily involve TM9 and/or TM11 and/or TM12 at the interface. Furthermore, we show that a palmitoyl group (palm) attached to hDAT on TM12 modifies the free energy of separation for interfaces involving TM12, suggesting that S-palmitoylation may change the relative abundance of dimers involving TM12 in a biological context. Finally, a comparison of the identified interfaces of hDAT and palmitoylated hDAT to the human serotonin transporter interfaces and the leucine transporter interface, suggests similar dimer conformations across these protein family. Nature Publishing Group UK 2021-02-18 /pmc/articles/PMC7893171/ /pubmed/33602981 http://dx.doi.org/10.1038/s41598-021-83374-y Text en © The Author(s) 2021 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Article Zeppelin, Talia Pedersen, Kasper B. Berglund, Nils A. Periole, Xavier Schiøtt, Birgit Effect of palmitoylation on the dimer formation of the human dopamine transporter |
title | Effect of palmitoylation on the dimer formation of the human dopamine transporter |
title_full | Effect of palmitoylation on the dimer formation of the human dopamine transporter |
title_fullStr | Effect of palmitoylation on the dimer formation of the human dopamine transporter |
title_full_unstemmed | Effect of palmitoylation on the dimer formation of the human dopamine transporter |
title_short | Effect of palmitoylation on the dimer formation of the human dopamine transporter |
title_sort | effect of palmitoylation on the dimer formation of the human dopamine transporter |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7893171/ https://www.ncbi.nlm.nih.gov/pubmed/33602981 http://dx.doi.org/10.1038/s41598-021-83374-y |
work_keys_str_mv | AT zeppelintalia effectofpalmitoylationonthedimerformationofthehumandopaminetransporter AT pedersenkasperb effectofpalmitoylationonthedimerformationofthehumandopaminetransporter AT berglundnilsa effectofpalmitoylationonthedimerformationofthehumandopaminetransporter AT periolexavier effectofpalmitoylationonthedimerformationofthehumandopaminetransporter AT schiøttbirgit effectofpalmitoylationonthedimerformationofthehumandopaminetransporter |